BEKhealth Raises $4 Million to Fuel Expansion Following Strong Customer Growth in 2024

RESEARCH TRIANGLE PARK, N.C., Feb. 13, 2025 | BEKhealth, an AI-powered chart abstraction and patient-matching platform company, announced today it raised $4 million to support its continued growth. This latest financing was co-led by Hatteras Venture Partners and Boston Millennia Partners with participation from existing investors Excelerate Health Ventures, Martin Ventures; and new investors RTI International and WakeMed Innovation Fund.

Today’s announcement follows strong customer growth in 2024, during which the company expanded its customer base, which now includes Avacare Clinical Research Network, Biopharma Informatics, Chemidox, Elixia Health, Gadolin Research, Innovo Research, Javara, Om Research, Prolerity Clinical Research, Rocket Trials, Sitebridge Research, Summit Clinical Research, Tekton Research, Velocity Clinical Research, and many more. BEKhealth brings an innovative AI-driven technology that integrates electronic health records (EHR) data to optimize population feasibility and rapidly identify clinically qualified participants for clinical research. The company plans to use this most recent round of capital to continue expanding its customer base and product offering.

“Research networks and drug developers that put the patient first will thrive in an industry that demands better designed trials, more qualified patients, and accelerated research access and enrollment. We look forward to working with the BEKhealth team as they scale their platform and services to meet a rapidly emerging and vital market opportunity,” said John Crumpler, General Partner, Hatteras Venture Partners.

Kelly Hollis, senior vice president, patient centered outcomes research at RTI Health Solutions, added, “Our investment and collaboration with BEKhealth will enable RTI to efficiently identify the right patients and gather deeper insights through integrated evidence generation across multiple data sources. Through this partnership, RTI will be able to connect real-time, real-world data with patient-provided insights to illuminate the full picture of the patient experience and patient journey with the goal of improving healthcare decision making.”

About BEKhealth

BEKHealth Corporation harnesses its AI-powered chart abstraction and patient-matching platform to help organizations conducting clinical trials, observational research, and real world evidence generation to better understand patient populations, optimize protocol design, population feasibility, and rapidly identify clinically qualified participants by extracting structured and unstructured data from electronic medical records (EMRs), leading to 10x more qualified patients and 2x faster enrollment. For more information, visit www.bekhealth.com.

About Hatteras Venture Partners
Founded in 2000 and based in Durham, NC, Hatteras Venture Partners is a venture capital firm with a focus on seed and early-stage healthcare investing. Through seven funds and over $800 million under management, the firm has invested in breakthrough science and cutting edge technology in the areas of biopharmaceuticals, medical devices, diagnostics, healthcare IT, and related opportunities in human medicine. To learn more, please visit www.hatterasvp.com.

About RTI International
RTI International is an independent, nonprofit research institute dedicated to improving the human condition. Clients rely on us to answer questions that demand an objective and multidisciplinary approach—one that integrates expertise across the social and laboratory sciences, engineering, and international development. We believe in the promise of science, and we are inspired every day to deliver on that promise for the good of people, communities, and businesses around the world. For more information, visit www.rti.org.

About RTI Health Solutions
As a business unit of RTI International, RTI Health Solutions (RTI-HS) provides consulting and research expertise to pharmaceutical, biotechnology, diagnostics, and medical device companies. Located across the US and Europe, our staff have led projects in approximately 80 countries. Our solutions include:

• Value, Access, and HEOR
• Patient-Centered Research
• Real-World Evidence
• Regulatory and Safety
• Strategic Consulting
• Medical Strategy and Communications

About WakeMed Innovation Venture Fund
About WakeMed Innovation Venture Fund brings subject-matter expertise, customer perspective, potential pilot and customer relationships. This benefits the investor process through improved due diligence, insight regarding the sales and implementation cycle, customer validation and credibility to lower risk of investment. This further benefits the portfolio company through insights from relevant experts, customer knowledge to improve the sales pitch, opportunities for product validation and early traction.

Excelerate Health Ventures
Excelerate Health Ventures is a management team of experienced healthcare operators with start-up, corporate, and investment expertise. EHV has a unique approach that leverages its investors – decision makers from pharma, providers, payers, and other strategic partners – to accelerate the adoption and revenues of their portfolio companies’ products and services. For more information, visit: https://www.exceleratehealth.com.

About Boston Millennia Partners
Boston Millennia Partners provides private equity financing to high growth companies in the healthcare and business services industries. Our team brings more than one hundred years of private equity experience to the investment and business building process. Our broad experience, combined with expertise in finance, operations, engineering, partnering with pharmaceutical companies, business development, executive recruiting, and law provides significant value to our portfolio companies. For more information, visit http://www.bostonmillenniapartners.com.

About Martin Ventures
Martin Ventures is a healthcare-focused venture capital firm based in Nashville, TN. The team is comprised of investors, entrepreneurs, and operators with over 220 years of healthcare experience. Martin Ventures focuses on building de novo companies and investing capital into growth-stage healthcare technology and technology-enabled services companies. For more information, visit www.martinventures.com.

Media Contact
David Levin | CEO @ BEKhealth
1 919-923-7801
dlevin@bekhealth.com